Literature DB >> 23583201

Paraventricular NUCB2/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats.

Udval Sedbazar1, Yuko Maejima, Masanori Nakata, Masatomo Mori, Toshihiko Yada.   

Abstract

Obesity often results from hyperphagia and involves rhythm disorder. Circadian feeding pattern is suggested to be implicated in energy homeostasis while its disorder in obesity. However, the mechanism underlying circadian feeding is little known. PVN is considered a regulatory center for feeding and circadian activities of hormone release and autonomic nerve. Nucleobindin2 (NUCB2) and its processing product nesfatin-1 (NUCB2/nesfatin-1) are localized in the hypothalamic paraventricular nucleus (PVN) and implicated in regulation of feeding. This study aimed to clarify whether the PVN NUCB2/nesfatin-1 expression exhibits diurnal rhythm and, if so, whether it is related to circadian feeding. Here we show that NUCB2 mRNA expression in the PVN rises during early light phase (LP) in parallel with suppression of food intake. Immunoneutralization of PVN NUCB2/nesfatin-1 with anti-nesfatin-1 IgG during LP, but not dark phase, increased food intake. PVN-selective shRNA-induced knockdown of NUCB2 mRNA expression elevated food intake. Furthermore, the rise of PVN NUCB2 mRNA during LP was blunted in Zucker-fatty obese rats which exhibited LP-preferential hyperphagia. The increases in food intake during LP and 24h were significantly corrected by intracerebroventricular injection of nesfatin-1 during LP. These results reveal the diurnal rhythm of PVN NUCB2 mRNA expression characterized by early LP rise, which may serve as a factor to limit LP food intake, contributing to circadian feeding. Furthermore, impaired NUCB2/nesfatin-1 rhythm may be related to dysregulated feeding pattern and hyperphagia in Zucker-fatty rats.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583201     DOI: 10.1016/j.bbrc.2013.03.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.

Authors:  A Stengel; Y Taché
Journal:  Horm Metab Res       Date:  2013-09-18       Impact factor: 2.936

Review 2.  The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.

Authors:  A Stengel; M Mori; Y Taché
Journal:  Obes Rev       Date:  2013-08-27       Impact factor: 9.213

3.  Study of the effects of nesfatin-1 on gastric function in obese rats.

Authors:  Guo-Tao Yang; Hong-Ying Zhao; Yu Kong; Ning-Ning Sun; Ai-Qin Dong
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

4.  Fibroblast growth factor 21, assisted by elevated glucose, activates paraventricular nucleus NUCB2/Nesfatin-1 neurons to produce satiety under fed states.

Authors:  Putra Santoso; Masanori Nakata; Kazuhiro Shiizaki; Zhang Boyang; Kumari Parmila; Zesemdorj Otgon-Uul; Koshi Hashimoto; Tetsurou Satoh; Masatomo Mori; Makoto Kuro-O; Toshihiko Yada
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

5.  Oxytocinergic cells of the posterior hypothalamic paraventricular nucleus participate in the food entrained clock.

Authors:  Mario Caba; Enrique Meza; Carolina Escobar; Angeles Jiménez; Mario Daniel Caba-Flores; María Luisa Moreno-Cortés; Angel I Melo
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

6.  Optogenetic activation of leptin- and glucose-regulated GABAergic neurons in dorsomedial hypothalamus promotes food intake via inhibitory synaptic transmission to paraventricular nucleus of hypothalamus.

Authors:  Zesemdorj Otgon-Uul; Shigetomo Suyama; Hiroshi Onodera; Toshihiko Yada
Journal:  Mol Metab       Date:  2016-06-24       Impact factor: 7.422

Review 7.  Role of Brain NUCB2/nesfatin-1 in the Stress-induced Modulation of Gastrointestinal Functions.

Authors:  Miriam Goebel-Stengel; Andreas Stengel
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.